158 related articles for article (PubMed ID: 35531909)
21. Non-invasive tissue Doppler imaging pulmonary capillary wedge pressure measurement improves NT-proBNP prognostic value in heart failure.
Berni A; Cappelli F; Bitossi L; Cecioni I; Cappelli B; Toncelli L; Galanti G; Poggesi L
Acta Cardiol; 2009 Apr; 64(2):213-8. PubMed ID: 19476114
[TBL] [Abstract][Full Text] [Related]
22. Dual-Shaped Silver Nanoparticle Labels for Electrochemical Detection of Bioassays.
Pollok NE; Peng Y; Raj N; Walgama C; Crooks RM
ACS Appl Nano Mater; 2021 Oct; 4(10):10764-10770. PubMed ID: 38404358
[TBL] [Abstract][Full Text] [Related]
23. Original signal amplification assay for N-Terminal pro-brain natriuretic peptide detection based on Bi
Xu R; Li J; Liu L; Liu X; Fan D; Cao W; Ma H; Wei Q
Anal Chim Acta; 2020 Mar; 1101():58-64. PubMed ID: 32029119
[TBL] [Abstract][Full Text] [Related]
24. Circulating fragments of N-terminal pro-B-type natriuretic peptides in plasma of heart failure patients.
Foo JY; Wan Y; Schulz BL; Kostner K; Atherton J; Cooper-White J; Dimeski G; Punyadeera C
Clin Chem; 2013 Oct; 59(10):1523-31. PubMed ID: 23820130
[TBL] [Abstract][Full Text] [Related]
25. NT-proBNP in monitoring treatment of patients with congestive heart failure.
Al-Meslmani BM; Fahoum SK; Shamia MG
Clin Lab; 2007; 53(1-2):35-9. PubMed ID: 17323823
[TBL] [Abstract][Full Text] [Related]
26. Measurement of NT-proBNP with LOCI technology in heart failure patients.
Gruson D; Ahn SA; Lepoutre T; Rousseau MF
Clin Biochem; 2012 Jan; 45(1-2):171-4. PubMed ID: 21843519
[TBL] [Abstract][Full Text] [Related]
27. Nanosensor electrical immunoassay for quantitative detection of NT-pro brain natriuretic peptide.
Panneer Selvam A; Prasad S
Future Cardiol; 2013 Jan; 9(1):137-47. PubMed ID: 23259480
[TBL] [Abstract][Full Text] [Related]
28. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure.
Bruins S; Fokkema MR; Römer JW; Dejongste MJ; van der Dijs FP; van den Ouweland JM; Muskiet FA
Clin Chem; 2004 Nov; 50(11):2052-8. PubMed ID: 15345664
[TBL] [Abstract][Full Text] [Related]
29. Macro-pro-B-type natriuretic peptide (proBNP) and hidden macro-N-terminal proBNP: Case report.
Nakagawa Y; Nishikimi T; Sakai H; Ohno S; Kinoshita H; Inazumi H; Moriuchi K; Kuwahara K; Horie M; Kimura T
Clin Biochem; 2018 Feb; 52():148-152. PubMed ID: 29103929
[TBL] [Abstract][Full Text] [Related]
30. Characterization of NT-proBNP in human urine.
Palmer SC; Endre ZH; Richards AM; Yandle TG
Clin Chem; 2009 Jun; 55(6):1126-34. PubMed ID: 19359532
[TBL] [Abstract][Full Text] [Related]
31. Application of a Fab fragment of monoclonal antibody specific to N-terminal pro-brain natriuretic peptide for the detection based on regeneration-free electrochemical immunosensor.
Yi W; Liang W; Li P; Li S; Zhang Z; Yang M; Chen A; Zhang B; Hu C
Biotechnol Lett; 2011 Aug; 33(8):1539-43. PubMed ID: 21452014
[TBL] [Abstract][Full Text] [Related]
32. A novel microfluidic immunoassay system based on electrochemical immunosensors: an application for the detection of NT-proBNP in whole blood.
Liang W; Li Y; Zhang B; Zhang Z; Chen A; Qi D; Yi W; Hu C
Biosens Bioelectron; 2012 Jan; 31(1):480-5. PubMed ID: 22169814
[TBL] [Abstract][Full Text] [Related]
33. NT-ProBNP levels in saliva and its clinical relevance to heart failure.
Foo JY; Wan Y; Kostner K; Arivalagan A; Atherton J; Cooper-White J; Dimeski G; Punyadeera C
PLoS One; 2012; 7(10):e48452. PubMed ID: 23119023
[TBL] [Abstract][Full Text] [Related]
34. Standardization of BNP and NT-proBNP Immunoassays in Light of the Diverse and Complex Nature of Circulating BNP-Related Peptides.
Semenov AG; Feygina EE
Adv Clin Chem; 2018; 85():1-30. PubMed ID: 29655458
[TBL] [Abstract][Full Text] [Related]
35. [Changes of serum N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases and its clinical significance].
Yang CL; Qiu YR; Zhou F; Feng PF
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):866-9. PubMed ID: 18504223
[TBL] [Abstract][Full Text] [Related]
36. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
Hess G; Runkel S; Zdunek D; Hitzler WE
Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of the analytical performance characteristics of NT-proBNP immunoassay on dimension RxL-HM (Dade Behring)].
Benoit MO; Dautezac F; Taccoen M; Paul JL
Ann Biol Clin (Paris); 2005; 63(4):411-6. PubMed ID: 16061439
[TBL] [Abstract][Full Text] [Related]
38. Ultrasensitive dynamic light scattering immunosensing platform for NT-proBNP detection using boronate affinity amplification.
Hu J; Ding L; Chen J; Fu J; Zhu K; Guo Q; Huang X; Xiong Y
J Nanobiotechnology; 2022 Jan; 20(1):21. PubMed ID: 34991601
[TBL] [Abstract][Full Text] [Related]
39. Single assay for amino-terminal fragments of cardiac A- and B-type natriuretic peptides.
Ala-Kopsala M; Ruskoaho H; Leppäluoto J; Seres L; Skoumal R; Toth M; Horkay F; Vuolteenaho O
Clin Chem; 2005 Apr; 51(4):708-18. PubMed ID: 15718490
[TBL] [Abstract][Full Text] [Related]
40. Sample-to-answer lateral flow assay with integrated plasma separation and NT-proBNP detection.
Strohmaier-Nguyen D; Horn C; Baeumner AJ
Anal Bioanal Chem; 2024 May; 416(13):3107-3115. PubMed ID: 38589616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
